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The dermis harbors a true dendritic cell population
that could elicit primary allogeneic T cell responses
in vitro and contact hypersensitivity reactions in vivo.
The origin of dermal dendritic cells remains poorly
understood, however. In this study, we analyzed the
fate of monocytes or monocyte-derived dendritic
cells in a dermal equivalent. Freshly isolated mono-
cytes or monocytes cultured for 6 d with either GM-
CSF/IL-4 or GM-CSF/IL-4/TGF-b1 (TGF-DC)
were seeded in a collagen solution with normal
human ®broblasts. The lattices were cultured for 7±
14 d in the presence, or absence, of the exogenous
cytokines, before phenotypic and functional studies
were performed. Supply of exogenous cytokines
allows the appearance of typical CD1a+/CD14±/
CD68low dendritic cells with signi®cant allostimula-
tory property, regardless of the cell type incorpor-
ated into the lattices. In cytokine-free conditions,
monocytes and GM-CSF/IL-4-derived dendritic cells
give rise to a CD1a±/CD14+/CD68high monocyte/
macrophage population with no allostimulatory
property. When incorporated into the lattices in the
absence of exogenous cytokines the TGF-DC express
few CD68 and FXIIIa. Interestingly, these cells do
not all convert into the CD14+/CD1a± population.
Indeed, a small HLA-DR+/CD1a+/CD14± subset was
consistently found, which represents about one-third
of the HLA-DR+ cells. Moreover, TGF-DC recov-
ered from the lattices after culture without cytokines
do display a signi®cant allostimulatory function.
Thus, in the absence of exogenous cytokines, only
Langerhans-cell-like dendritic cells can retain the
typical dendritic cell features when inserted in a der-
mal environment. Taken together, these results may
provide evidence supporting an epidermal origin of
dermal dendritic cells. Key words: collagen lattices/der-
mal dendritic cells/Langerhans cells/macrophages. J Invest
Dermatol 116:933±939, 2001
D
endritic cells (DC) are bone marrow derived cells
that are characterized by a strong constitutive
expression of MHC class II antigens and by their
unique capacity to elicit speci®c immune responses
from naive T cells (Steinman, 1991). DC are found
in many lymphoid and nonlymphoid organs, as well as circulating
in the blood stream. Among MHC class II positive cells displaying
elongate morphology and initially called dermal dendrocytes
(Meunier, 1996), the dermis harbors a true DC population that
can elicit contact hypersensitivity reactions in vivo (Streilein et al,
1989; Tse and Cooper, 1990) and primary allogeneic T cell
responses in vitro (Lenz et al, 1993; Meunier et al, 1993; Nestle et al,
1993). This DC population remains poorly characterized, however.
Upon enzymatic digestion, a dermal subset has been identi®ed that
shows a close relationship to epidermal Langerhans cells because of
CD1a and CD32 expression and lack of CD36 antigens. The cells
express FXIIIa and, as typical DC, they display a potent
allostimulatory property (Meunier et al, 1993). Other DC subsets
have been described, displaying strong stimulatory capacity but
lacking CD1a expression (Nestle et al, 1993; 1998). This
phenotypic heterogeneity may re¯ect different maturation steps
but also different dermal DC origins.
In vitro, human monocytes can be directed to develop into
potent immunostimulatory DC when cultured in the presence of
granulocyte-macrophage colony stimulating factor (GM-CSF) and
interleukin-4 (IL-4) (Sallusto and Lanzavecchia, 1994; Romani et
al, 1994). According to their phenotype, these cells have been
related to dermal DC because they were nearly all CD11b and
FXIIIa positive (Grassi et al, 1998). Moreover, they contained
intracytoplasmic granules that were different from Langerhans cell
Birbeck granules but comparable to those of CD14-derived DC
obtained from cord blood precursors (Caux et al, 1996). On the
other hand, Geissmann et al (1998) showed that CD14+ monocytes
in the presence of GM-CSF/IL-4/transforming growth factor b1
(TGF-b1) could acquire the Langerhans cell characteristic
phenotype, i.e., CD1a+, E-cadherin+, cutaneous lymphocyte-
associated antigen+, and Langerhans antigen granule+. The concept
that monocytes can become DC under physiologic conditions was
supported by the observation that monocytes differentiate into DC
in an in vitro model of transendothelial traf®cking without addition
of exogenous cytokines (Randolph et al, 1998). In this study, we
analyzed the in¯uence of a dermal-like environment on the
differentiation of putative dermal DC precursors. To this end,
monocytes or monocyte-derived DC cultured with either GM-
CSF/IL-4 (referred to as DC) or GM-CSF/IL-4/TGF-b1 (referred
to as TGF-DC) were introduced in a dermal equivalent. The
system was composed of the main dermal components, i.e., normal
human ®broblasts and collagen I. The lattices were cultured for 7±
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14 d in medium supplemented or not with exogenous cytokines,
and morphology, phenotype, and allostimulatory function of the
cells were analyzed.
MATERIALS AND METHODS
Culture medium The culture medium was RPMI-1640 supplemented
with L-glutamine (Gibco BRL, Grand Island, NY), 1% antibiotic
solution (Sigma, St. Louis, MO), and 10% heat-inactivated fetal bovine
serum (FCS Myoclone, Gibco BRL), referred to below as complete
medium.
Isolation of human monocytes and preparation of monocyte-
derived DC Mononuclear cells were obtained from peripheral blood
of healthy donors by centrifugation on Ficoll-Hypaque (Pharmacia, St.
Quentin en Yvelines, France). Cells (40 3 106) were sequentially layered
on a discontinuous Percoll gradient (50% and 40% in phosphate-buffered
saline, 5% fetal calf serum) and centrifuged at 450g for 25 min at 4°C.
Monocyte-enriched cells (nearly 70%) were collected from the interface
over the 50% Percoll solution and lymphocytes were collected from the
cell pellet. Monocytes were puri®ed by negative magnetic depletion
using hapten-conjugated anti-CD3, CD7, CD19, CD45RA, CD56
(MACS; Miltenyi Biotec, Bergisch Gladbach, Germany) and a magnetic
cell separator (Midi MACS) according to the manufacturer's instructions.
The technique routinely resulted in more than 95% CD14+ cells.
Puri®ed monocytes were cultured for 6 d in six-well tissue culture
plates (Costar, Cambridge, MA) in complete medium supplemented with
200 ng per ml rhGM-CSF (speci®c activity 2 3 106 U per mg;
Schering-Plough Research, Kenilworth, NJ) and 33 ng per ml IL-4
(speci®c activity 5 3 106±20 3 106 U per mg; R&D Systems,
Minneapolis, MN) or with rhGM-CSF + IL-4 + 10 ng per ml TGF-b1
(speci®c activity 16 3 106±50 3 106 U per mg; R&D Systems). At days
2 and 4, cells were fed with fresh medium and cytokines.
In some experiments, day 6 monocyte-derived DC were induced to
mature upon a 40 h stimulation with CD40 ligand transfected ®broblasts
(a generous gift from Schering-Plough Laboratories, Dardilly, France).
Dermal equivalents Dermal equivalents were prepared as previously
described (Gentilhomme et al, 1999). Brie¯y, normal human ®broblasts
were obtained from newborn dermis by standard collagenase procedure.
Fibroblasts, at passages ranging from 3 to 6, were seeded in a 2 mg per
ml solution of type I rat tail collagen (Institut J. Boy, Reims, France) at a
density of 25 3 104 cells per lattice according to Bell's methodology
(Bell et al, 1983). Monocytes or day 6 DC were coseeded at a density of
25 3 104 cells per lattice. The lattices were cultured in Dulbecco's
modi®ed Eagle's medium containing 4.5 g per liter glucose
supplemented with 10% fetal bovine serum, 100 U per ml penicillin, and
100 mg per ml streptomycin (all from Life Technologies, Grand Island,
NY). The medium was supplemented or not with the GM-CSF/IL-4 or
GM-CSF/IL-4/TGF-b1 cocktails. Lattice cultures lasted 7 or 14 d for
monocytes and 7 d for DC or TGF-DC.
Immunohistochemistry Dermal equivalents were embedded and
rapidly frozen in Tissue Tek II, OCT compound (Miles Laboratory,
Elkhart, IN) and stored at ±20°C. Subsequently, 4 mm cryosections were
cut and air-dried. A panel of antibodies was used in an indirect
immuno¯uorescence labeling technique: anti-HLA-DR (IgG2a; Becton
Dickinson, Le Pont de Claix, France); anti-CD14, My4 (IgG2b; Coulter,
Immunology, Miami, FL); anti-CD1a, DMC1 (IgG1; INSERM U346,
Lyon, France); anti-CD68, KP1 (IgG1 from Dako, Glostrup, Denmark);
anti-E-cadherin, HECD-1 (IgG1; Takara, Shiga, Japan); polyclonal
antibody rabbit anti-Factor XIIIa (Behringwerke, Marburg, Germany);
anti-CD86, IT2.2 (IgG1; Pharmingen, San Diego, CA), anti-CD83,
HB15A, and anti-DC-LAMP (CD208) 104.G4 (IgG1, from
Immunotech, Marseille, France); anti-Langerin (CD207) DCGM4 (IgG1;
Schering-Plough Laboratories); CD11b, LeuTM-15, IgG2a from Becton
Dickinson (San Jose, CA); or isotype controls (IgG1, IgG2a, IgG2b).
Cryosections were incubated with optimal concentrations of the primary
antibody and visualized with secondary antibody for immuno¯uorescence
microscopy analysis.
Lattice digestion Lattices were digested for 1 h at 37°C by 1 mg per
ml collagenase D (from Clostridium histolyticum; Boehringer Mannheim,
Germany) in phosphate-buffered saline. Cells were washed and
enumerated, and cell viability was assessed by the trypan exclusion test.
Cells were then stained for cyto¯uorimetry or used in a mixed
lymphocyte reaction (MLR) assay.
Flow cytometry Brie¯y, 2 3 105 cells were incubated for 20 min at
4°C with af®nity puri®ed mouse monoclonal antibodies at the
appropriate concentration or with control isotype-matched irrelevant
monoclonal antibodies at the same concentration. Cells were washed and
for indirect staining incubated for 20 min at 4°C with ¯uorescein
isothiocyanate (FITC) conjugated goat F(ab)¢2 antimouse Ig. The
following monoclonal antibodies were used: anti-HLA-DR-FITC,
B8.12.2 (IgG1) from Immunotech; anti-CD1a-FITC, BB-1; anti-CD14-
FITC, TUÈ K 4 (IgG1) from Dako; anti-E-cadherin, HECD-1 (IgG1,
Takara).
For double-color ¯uorescence, cells were successively stained with
anti-HLA-DR-tri-color, T<36 (IgG2b), and anti-CD1a-FITC or anti-
CD14-FITC.
Intracellular staining for Factor XIIIa (FXIIIa, polyclonal rabbit
antiserum, Behringwerke) was carried out using the ``®x and perm'' cell
permeabilization kit (Caltag Laboratories), according to the manufactur-
er's instructions. Cells were washed twice and primary antibodies were
visualized with goat antirabbit conjugated to FITC.
For all labeling experiments, analysis was performed on the FACScan
using the LYSYS II software (Becton Dickinson).
MLR Total cells recovered from the lattices were irradiated (70 Gray)
to avoid normal human ®broblast proliferation. The number of
stimulator cells added in the assay was derived from the percentage of
HLA-DR+ within the total dermal cell suspension, as assessed by
cyto¯uorimetry analysis (7%±30%, according to the experiments).
Allogeneic T cells were isolated from the lymphocyte pellet obtained
after Percoll gradient by rosetting with sheep red blood cells as previously
described (Kaplan and Clark, 1974). The T cell population contained
95% or more CD3 positive cells, as assessed by cyto¯uorimetry. The cells
were cultured in round-bottomed microtiter plates (105 allogeneic T
cells with graded numbers of DC in complete medium in a 200 ml ®nal
volume per well) at 37°C in a humidi®ed atmosphere of 5% CO2.
Triplicate cultures were maintained for 5 d. T cell proliferation was
measured by pulsing the cells with 1 mCi of 3H-methylthymidine (25 Ci
per mmol; Amersham, Les Ulis, France) for the ®nal 18 h of culture.
Cells were then harvested and incorporated thymidine was quantitated in
a direct beta-counter (Matrix 96, Packard Instruments, Meriden, CT).
Ultrastructure Lattices were ®xed in 2% glutaraldhyde in cacodylate
buffer at 4°C for at least 3 d. The samples were post®xed for 60 min
with 1% osmium tetroxide in cacodylate buffer with sucrose, dehydrated,
and embedded in epoxy medium. Ultrathin sections were examined after
poststaining with uranyl acetate and lead citrate and analyzed on a JEOL
1200 EX electron microscope (CMEABG, UniversiteÂ Lyon, France).
RESULTS
Cell phenotype before incorporation into the lattices The
phenotype of freshly isolated monocytes and monocyte-derived
DC is shown in Fig 1. These DC have been cultured for 6 d in
either GM-CSF/IL-4 (DC) or GM-CSF/IL-4/TGF-b1 (TGF-
DC).
Monocytes faintly expressed HLA-DR and were negative for
CD1a whereas these markers were strongly expressed on both DC
types. All the cells displayed intracytoplasmic FXIIIa, a marker
characteristic of dermal DC (Cerio et al, 1989; Lenz et al, 1993;
Nestle et al, 1993). Only TGF-DC expressed the Langerhans-cell-
related molecule E-cadherin. As reported by Geissmann et al (1998)
and assessed by electron microscopy analysis, the TGF-DC
exhibited rod-shaped intracytoplasmic structures that resembled
Birbeck granules, except that the central lamella was interrupted or
absent (not shown). Langerin expression was never detected on the
DC and very occasionally on the TGF-DC. Both cell types display
an immature phenotype, as assessed by the lack of CD83 and
CD208 (DC-LAMP) staining (not shown).
As previously reported, we found that, unlike fresh monocytes,
monocyte-derived DC displayed a potent allostimulatory property.
Indeed, as few as 103 DC or TGF-DC were able to induce half
maximal T cell proliferation in the MLR assay (data not shown).
Phenotype of monocyte or monocyte-derived dendritic
cells incorporated into the lattice
Immunohistochemistry on lattice cryosections We examined the
outcome of monocytes or monocyte-derived DC inside the
lattices of collagen I retracted by normal human ®broblasts. To
934 GUIRONNET ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
this aim, monocytes and day 6 DC or TGF-DC were seeded into
the lattices and cultured in the presence or not of GM-CSF/IL-4
(for monocytes and DC) or GM-CSF/IL-4/TGF-b1 (for TGF-
DC). Immunohistochemistry analysis was performed 7 d later. For
monocytes, immunohistochemistry analysis was also carried out
after 14 d and the results were similar.
We ®rst tried to detect HLA-DR, FXIIIa, and CD68 antigens,
some myelo-monocytic markers that are not expressed by normal
human ®broblasts. All the markers were found in lattices seeded
with monocytes or DC, in the presence or not of exogenous
cytokines, showing that, in both conditions, cells of interest could
insert and stay in the lattices (Fig 2). Addition of GM-CSF/IL-4 to
the cultures, however, resulted in fewer brightly stained CD68+
cells (Fig 2).
Interestingly, the lattices seeded with TGF-DC exhibited a
similar number of HLA-DR+ cells but far fewer FXIIIa+ and
CD68+ cells, compared to the dermal equivalent seeded with
monocytes or DC (not shown).
Whatever the culture conditions, the stained cells displayed
elongate morphology. Staining of HLA-DR showed quantitative
variations upon addition of exogenous cytokines. Thus, cells
cultured in cytokine-free medium consistently exhibited a lower
HLA-DR intensity than cells inserted into lattices that received
exogenous cytokines (Fig 2).
We then analyzed the presence of monocytes/macrophages or
DC speci®c antigens, like CD14 and CD1a, respectively. Overall,
the lattices cultured in cytokine-free medium contained a high
number of CD14+ cells whereas CD1a+ cells were rarely observed.
One exception was that in the lattices seeded with TGF-DC a
signi®cant number of CD1a+ cells was consistently detected (not
shown). The CD14+ to CD1a+ ratio was reversed in lattices
supplied with exogenous cytokines (Fig 2).
E-cadherin expression was never found although all TGF-DC
expressed the antigen before seeding. Langerin (CD207) expression
was always negative. In all culture conditions, a very weak staining
was observed with anti-CD11b, which is normally expressed on
monocytes/macrophages and monocyte-derived DC. B7.2, CD83,
and CD208 (DC-LAMP) that characterize mature DC never
stained the lattice cryosections (data not shown).
Fluorescence-activated cell sorter (FACS) analysis of HLA-DR
populations recovered from the lattices Lattices were digested with
collagenase D to isolate the cells integrated into the lattices and
perform more accurate phenotypic analysis. Thus, double staining
of HLA-DR+ cells was carried out, using either anti-CD1a or
CD14 monoclonal antibodies, and the cells were analyzed by FACS
analysis.
In all the culture conditions, the mortality of cells recovered
from the lattices did not exceed 10%, as assessed by the trypan blue
exclusion test. Furthermore, the yield of DC was similar, as assessed
by HLA-DR staining and FACS analysis of the dermal cell
suspensions. According to the experiments it averaged 30.4 6
11.6% with values ranging from 8% to 40% (mean 6 SD of four
experiments).
As shown in Fig 3, the recovered cells were nearly all HLA-
DR+/CD14±/CD1a+, provided the lattice cultures were carried
out in the presence of exogenous cytokines. By contrast, when
seeded into the lattices in cytokine-free medium, monocytes or DC
became nearly all HLA-DR+/CD14+/CD1a± cells. Interestingly,
the TGF-DC cultured in the absence of exogenous cytokines
behaved in a somewhat different way. Although most of the cells
expressed CD14 and lacked CD1a at the cell surface, a signi®cant
proportion of the cells were indeed HLA-DR+/CD14±/CD1a+
(one-third of the HLA-DR dermal cell population, Fig 3).
Allogeneic function of cells incorporated into the
lattices The best criterion for characterizing DC is their
allostimulatory capacity (Steinman, 1991). We thus tested the
ability of cells recovered from the lattices to activate naive
allogeneic T cells in MLR assays. As shown in Fig 4, monocytes,
DC, and TGF-DC recovered from the lattices supplied with
cytokines exhibited a signi®cant stimulatory capacity. In some
experiments, we compared the DC allostimulatory property before
Figure 1. Flow cytometry analysis of the
cells before incorporation into the lattices.
Freshly isolated monocytes and day 6 monocyte-
derived DC cultured in either GM-CSF/IL-4
(DC) or GM-CSF/IL-4/TGF-b1 (TGF-DC)
were stained with different monoclonal antibodies
(closed histograms). Cytometry analysis was
performed without gating. Open histograms give
the reactivity with the appropriate isotype-
matched control monoclonal antibodies. Data are
from one representative experiment out of 20
routinely executed.
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and after their insertion into the lattices with that of mature DC
stimulated for 40 h with CD40 ligand. We found that DC
exhibited a similar stimulatory property before and after insertion
into the lattices, provided exogeneous cytokines were supplied. By
contrast, they displayed a far lower stimulatory property than
mature DC (not shown).
The allostimulatory property of monocytes or DC from
cytokine-free lattices was close to that of fresh monocytes, used
as controls. By contrast, TGF-DC cultured without cytokines
retained a signi®cant capacity to stimulate allogeneic T cells
(Fig 4). Indeed, in three separate experiments T cell proliferation
induced by TGF-DC was signi®cantly higher than that obtained
with fresh monocytes. Note that, in all these experiments,
thymidine incorporation was measured by a direct beta-counter,
which explains the low cpm value.
Lattices ultrastructure As shown in Fig 5, the cells
incorporated into the lattices displayed similar morphologic
features regardless of culture conditions. The cells were large
with elongated and irregular shape, depending on the section
direction. They exhibited immature myeloid cell features such as a
large clear cytoplasm with numerous organelles and a moderate
dendricity. Furthermore, many earlier endocytic structures, like
coated pits and coated vesicles (Figs 5, 2, 4), and a low number of
class II compartments were found in the cytokine-supplied lattices.
Collagen ®ber phagocytosis or phagosome structures, typical of
®nally differentiated macrophages, were never observed but many
vacuoles were present. On the other hand, we never detected DC
with Birbeck granules inside the lattices. Importantly, neither
apoptotic cells nor cellular lysis were observed, demonstrating that
the cells were alive inside the lattices.
Figure 2. Immunostaining of lattice
cryosections after incorporation of GM-CSF/
IL-4-derived DC. DC were seeded in dermal
equivalents and cultured for 7 d without cytokines
or in the presence of exogenous GM-CSF/IL-4
(+ cytokines). Four micron lattice cryosections
were stained using control Ig, HLA-DR, CD14,
CD1a, CD68, and FXIIIa and were observed by
¯uorescence microscopy. Scale bar, 50 mm. Results
are representative of three experiments.
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DISCUSSION
The dermis harbors heterogeneous DC populations, the origin of
which is still debated. Dermal DC may represent a resident
population, immature DC derived from blood precursors en route
to the epidermal compartment, or Langerhans cells migrating from
epidermis.
This study was aimed at analyzing the fate of monocytes, or
monocyte-derived DC, inserted in a dermal equivalent. Immuno-
histochemistry of the lattice cryosections and ultrastructure showed
that, in any culture conditions, the inserted cells displayed elongate
morphology. As in human dermis, however, this morphology does
not necessarily equate with a population of dendritic professional
antigen-presenting cells, as revealed by functional assays. Electron
microscopy analysis demonstrated that all the incorporated cells
were alive in the lattices, contrasting with the rapid mortality of
mature spleen DC or Langerhans cells when inserted in a similar
dermal equivalent (Gunzer et al, 2000). We found that all the
Figure 3. Double staining and ¯ow cytometric analysis of cells recovered from the lattices. Monocytes, DC, or TGF-DC were seeded into
lattices and cultured for 7 d in the presence or not (+0) of exogenous cytokines. Lattices were then digested with collagenase and the isolated cells
were double stained using anti-HLA-DR-tri-color (y axis) and anti-CD14-FITC or anti-CD1a-FITC (x axis). Quadrant setting was performed
according to the reactivities of isotype-matched control monoclonal antibodies. Results are representative of at least ®ve experiments.
Figure 4. Allostimulatory property of the
cells isolated from the lattices. Monocytes (a),
GM-CSF/IL-4-derived DC (DC) (b), or GM-
CSF/IL-4/TGF-b1-derived DC (TGF-DC) (c)
were seeded into lattices and cultured for 7 d with
or without the exogenous cytokines (®lled squares
and open circles, respectively). Lattices were then
digested and, after irradiation, the recovered cells
were added to allogeneic T cells in an MLR assay.
The stimulator cell number corresponds to the
number of HLA-DR+ cells in the dermal
suspensions, as assessed by ¯ow cytometry analysis.
As negative controls, freshly isolated monocytes
were tested in MLR (®lled triangles). All the tests
were carried out in triplicate and T cell
proliferation was assessed by 3H-thymidine
incorporation during the last 18 h of culture.
Results are expressed as mean cpm 6 SD and are
representative of three independent experiments.
The cpm value for T cells alone or DC alone did
not exceed 40 cpm.
VOL. 116, NO. 6 JUNE 2001 DENDRITIC CELLS SEEDED IN A DERMAL EQUIVALENT 937
incorporated cells displayed immature myeloid cell ultrastructural
features, which makes it dif®cult to argue about their monocyte/
macrophage or DC lineage commitment.
When freshly isolated monocytes were seeded into the lattices in
the absence of exogenous cytokines, however, the incorporated
cells stained brightly with CD14, FXIIIa, and CD68 monoclonal
antibodies and most of the HLA-DR+ cells were CD14+ and
CD1a±. Furthermore, the cells did not display potent allostimula-
tory function. The results demonstrated that monocytes incorpor-
ated in the dermal equivalent were not able to differentiate into
DC, but rather into the monocyte/macrophage population. Using
an in vitro model of transendothelial traf®cking, Randolph et al
demonstrated that exposure to endothelial cells might be an
essential stimulus for a rapid differentiation of monocytes into DC
(Randolph et al, 1998). They showed that monocytes could
differentiate into mature DC providing they received a phagocytic
stimulus in subendothelial collagen and then migrated in the basal-
to-apical direction. They also found that cells remaining into the
subendothelial matrix became macrophages, which agrees with our
results.
As reported by others, we found that GM-CSF/IL-4-derived
DC shared many phenotypic features with dermal DC, such as
CD1a and FXIIIa expression. When inserted into the lattice under
cytokine-free conditions, however, these DC lost CD1a expres-
sion, acquired CD14, and stained brightly with CD68 monoclonal
antibodies but faintly with HLA-DR. Concurrently, they lost their
allostimulatory property. All these changes indicated that GM-
CSF/IL-4-derived DC could survive in a dermal environment but
could not retain their DC state and converted into the monocyte/
macrophage lineage. The results underline the plasticity of
monocyte-derived DC, as previously reported in studies using
cell suspensions. Indeed, day 5 monocyte-derived dendritic cells
cultured in cytokine-free medium for 2 d became CD1a± CD14+
macrophages (Palucka et al, 1998).
It is possible that our lattice model does not entirely ful®ll the
environmental conditions of normal dermis or that the maturation
step of DC was incomplete. Alternatively, the above-mentioned
results may suggest that the normal dermis environment would
favor the differentiation of monocytes and GM-CSF/IL-4-derived
immature DC into monocytes/macrophages rather than into DC.
In support of this view, many studies (Sontheimer et al, 1989;
Lonati et al, 1996) have suggested that most of the dermal myelo-
monocytic cells have phenotype and ultrastructure more closely
related to monocytes/macrophages than to DC. Interestingly, these
cells were not randomly distributed through the dermis but shared
an intimate relationship with the dermal microvasculature, sug-
gesting that they derived from circulating precursors such as
monocytes.
TGF-b1 is synthesized at high levels by epithelial cells and is
required for the development of Langerhans cells in vivo
(Borkowski et al, 1996; 1997). In vitro, several studies have shown
that TGF-b1 could polarize DC differentiation towards the
Langerhans cell pathway (Geissman et al, 1998; Strobl et al, 1998;
Caux et al, 1999; Zhang et al, 1999). In agreement with this ®nding,
we found that TGF-DC expressed E-cadherin, a typical Langerhans
cell marker. When inserted into the lattices in the absence of
exogenous cytokines, TGF-DC behaved differently from mono-
cytes or GM-CSF/IL-4-derived DC. First, they expressed far less
FXIIIa and CD68. Second, they did not all convert into HLA-
DR+/CD14+/CD1a± monocytes/macrophages. Indeed, a small
HLA-DR+/CD1a+ subset was consistently found, which repre-
sents about one-third of the HLA-DR+ cells recovered from the
Figure 5. Electron microscopy analysis of
the cells inside the lattices. DC (1±2) or TGF-
DC (3±4) were seeded in the dermal equivalents
and cultured for 7 d with (1±3) or without (2±4)
the exogenous cytokines. Lattices were then
processed for electron microscopy analysis.
Ultrathin sections were examined on a JEOL
1200 EX electron microscope. Inserts: endocytic
structures.
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lattices. It is tempting to speculate that the CD1a+ population could
account for the signi®cant allostimulatory property of the recovered
cells. Furthermore, the TGF-DC lost E-cadherin expression when
entering the dermal equivalent, as did epidermal Langerhans cells
when they left their epidermal environment (Tang et al, 1993;
Jakob and Udey, 1998; Jakob et al, 1999). All these results suggested
that following the TGF-b1 signal a subset of cells inside the lattices
did not convert into monocytes/macrophages but retained their
DC state. The latter result might provide an additional argument
for an epidermal origin of dermal DC. In line with this, Meunier et
al (1993) demonstrated that the dermal DC subset that is the most
potent in inducing T cell activation is very close to Langerhans
cells. In the same way, Sepulveda-Merrill et al (1994) and
Duraiswamy et al (1994) showed that in normal human dermis
and murine dermis, respectively, the dendritic antigen-presenting
cell resides in the Langerhans-cell-like population. More recently,
in the context of skin in¯ammation by Candida albicans, Katou et al
observed that the majority of antigen-presenting capacity resides in
the dermal Langerhans cell population whereas FXIIIa dermal
dendrocytes were not involved (Katou et al, 2000).
For all cell types seeded into the lattices, we found that addition
of exogenous cytokines allowed the differentiation of CD1a+
CD14± cells displaying strong allostimulatory capacity, all features
being characteristics of DC. The results emphasized the need for
GM-CSF + IL-4 in DC differentiation from monocytes. Whether
other cytokines could substitute for the GM-CSF + IL-4 effect
under in vivo conditions is questionable. Indeed, the GM-
CSF + IL-4 environment is unlikely to be ful®lled in the dermis
at least under normal conditions. One cannot exclude, however,
that in some cutaneous diseases in which the Th2 cytokine pro®le
predominates, such as atopic dermatitis, dermal T cells would
secrete these factors and thus allow DC differentiation from dermal
monocytes/macrophages.
Finally, the lattices cultured with monocytes in GM-CSF + IL-4
supplemented medium or with TGF-DC in cytokine-free medium
provide for the ®rst time an immunocompetent dermal model. This
model might be very useful for studying the immune function of
dermal cells under normal or pathologic conditions such as
hypersensitivity contact reactions or HIV infections.
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